Out-of-Pocket Costs Put Arthritis Drugs Out of Reach for Some

People with rheumatoid arthritis whose health insurance requires them to pay a higher share of the cost are less likely to use biotech drugs than those with coverage that is more generous. High family medical bills also appear to reduce the use of these powerful but expensive medications, according to a new study in Health Services Research.

Read the whole article on Physorg

More from Physorg